Kyri van Hoose
Director of Finance/CFO chez DERMATA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Kyri K.
van Hoose is currently the Vice President-Accounting at Turning Point Therapeutics, Inc. and the Chief Financial Officer & Senior Vice President at Dermata Therapeutics, Inc. Previously, Kyri held the position of Corporate Controller & Senior Director-Finance at ACADIA Pharmaceuticals, Inc. from 2005 to 2016.
In 2019 to 2020, Kyri was the Head-Finance at Curzion Pharmaceuticals, Inc. and from 2020 to 2021, Kyri served as the Chief Financial Officer at TEGA Therapeutics, Inc. Kyri completed an undergraduate degree at the University of Southern California in 2000 and obtained an MBA from the University of California, Irvine in 2005.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Kyri van Hoose
| Sociétés | Poste | Début |
|---|---|---|
| TURG POIN | Comptroller/Controller/Auditor | 05/05/2021 |
| DERMATA THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2021 |
Anciens postes connus de Kyri van Hoose
| Sociétés | Poste | Fin |
|---|---|---|
TEGA Therapeutics, Inc.
 TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Director of Finance/CFO | 30/04/2021 |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/04/2020 |
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/02/2016 |
Formation de Kyri van Hoose
| University of Southern California | Undergraduate Degree |
| University of California, Irvine | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Health Technology |
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Health Technology |
